Last $5.05 USD
Change Today +0.07 / 1.41%
Volume 13.3K
CCXI On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 2:26 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Kamm M.D.

Member of Clinical Advisory Board, ChemoCentryx, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 2 different industries.

See Board Relationships
----

Background*

Prof. Michael Kamm, M.D. serves as the chairman of medicine and director Inflammatory Bowel Disease, University and St. Vincents Hospital, Melbourne (AUS). Dr. Kamm serves as a Professor of Gastroenterology and Director of Physiology Unit, St. Mark's Hospital, Harrow, England. Dr. Kamm serves as professor of gastroenterology, Karolinska Institutet, Stockholm (SWE) and head of the IBD unit, Sophiahemmet in Stockholm and chairman of the Swedish organization for the study ...

Read Full Background

Corporate Headquarters*

850 Maude Avenue
Mountain View, California 94043

United States

Phone: 650-210-2900
Fax: 650-210-2910

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $5.05 USD +0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Herve Hoppenot Chief Executive Officer, President and Director
Incyte Corporation
--
Yasuchika Hasegawa Chairman of the Board and Chief Executive Officer
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.